Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis by Ramos-Cejudo, Jaime et al.
Spatial and Temporal Gene Expression Differences in
Core and Periinfarct Areas in Experimental Stroke: A
Microarray Analysis
Jaime Ramos-Cejudo1., Marı´a Gutie´rrez-Ferna´ndez1., Berta Rodrı´guez-Frutos1, Mercedes Expo´sito
Alcaide1, Fa´tima Sa´nchez-Cabo2, Ana Dopazo3, Exuperio Dı´ez–Tejedor1*
1Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health
Research Institute), Auto´noma University of Madrid, Madrid, Spain, 2 Bioinformatics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain,
3Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
Abstract
Background: A large number of genes are regulated to promote brain repair following stroke. The thorough analysis of this
process can help identify new markers and develop therapeutic strategies. This study analyzes gene expression following
experimental stroke.
Methodology/Principal Findings: A microarray study of gene expression in the core, periinfarct and contralateral cortex
was performed in adult Sprague-Dawley rats (n = 60) after 24 hours (acute phase) or 3 days (delayed stage) of permanent
middle cerebral artery (MCA) occlusion. Independent qRT-PCR validation (n = 12) was performed for 22 of the genes.
Functional data were evaluated by Ingenuity Pathway Analysis. The number of genes differentially expressed was 2,612
(24 h) and 5,717 (3 d) in the core; and 3,505 (24 h) and 1,686 (3 d) in the periinfarct area (logFC.|1|; adjP,0.05). Expression
of many neurovascular unit development genes was altered at 24 h and 3 d including HES2, OLIG2, LINGO1 and NOGO-A;
chemokines like CXCL1 and CXCL12, stress-response genes like HIF-1A, and trophic factors like BDNF or BMP4. Nearly half of
the detected genes (43%) had not been associated with stroke previously.
Conclusions: This comprehensive study of gene regulation in the core and periinfarct areas at different times following
permanent MCA occlusion provides new data that can be helpful in translational research.
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Introduction
Clinical management of stroke, a major cause of death and
disability all over the world, still requires effective new therapeutic
targets and markers. Most trials based on neural protection or
immune-suppression have failed or obtained poor results, and
effort and interest are now dedicated to the development of new
strategies that could enhance naturally-occurring endogenous self-
repair processes [1]. Genetic research has constantly revealed that
plasticity and resilience exist in both the developing and the adult
brain [2] and great efforts have gone into unraveling the molecular
events underlying reorganization and plasticity following stroke
damage [3], [4], [5]. While it is accepted that such processes
become activated, most are still not completely identified [6], [7],
[8].
Gene expression levels can vary in different brain areas
subjected to ischemic conditions and also across the different
stages of the ischemic cascade. In this sense, the broad view of
regulation provided by microarray analysis can offer new insight
into mechanisms of stroke and repair [9]. Using this technique to
focus on the periinfarct area 24 h after transitory focal cerebral
ischemia, earlier authors identified potential new tissue repair and
plasticity targets as well as multiple transcripts not previously
associated with stroke [10]. Most gene expression studies to date
have focused on transitory ischemia, but transcriptional events
after permanent occlusion - a common condition in stroke patients
- has received little attention. Indeed, the mechanisms of infarct
evolution and the responsiveness of lesions are not necessarily
equivalent from one model to another [11] and therefore, the
information provided after analyzing responsiveness to permanent
occlusion can also be useful.
In the last decade the emerging concept of penumbra has
gained importance in terms of metabolism and cellular signals and
is now considered a diagnostic and biochemical target as well as
the starting point for studying brain plasticity [12]. Classically
defined as hypoperfused and functionally compromised tissue
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surrounding the ischemic core of the lesion, both the definition of
penumbra and its clinical implications have constantly evolved.
After volumetric analysis, including quantitative ADC and CBF
voxel compartmental analysis, of temporal evolution after
permanent middle cerebral artery occlusion, it was recently
reported that the distribution pattern of the penumbra was rather
complex and did not follow the classically-described pattern
surrounding a central core [13]. It has also recently been reported
[14] that metabolic status and spreading depolarization of
periinfarct neurons is critical for the recruitment of these neurons
into the ischemic core over time. Thus, not only blood flow or
glucose/O2 deprivation–induced stress but also metabolic status
have been shown to be critical. Understanding the differences
between the core of the lesion and the surrounding compromised
periinfarct (PI) areas could well offer new targets and strategies for
the treatment of stroke. Indeed, recent efforts have been made to
analyze the metabolic evolution of both areas after both transitory
and permanent occlusion [15].
From this perspective, the manner in which gene expression is
modulated in different areas of the brain after permanent ischemia
has not yet been studied with microarrays and such information
could be of great interest.
The present study has used microarray technology to identify
thousands of genes whose expression is significantly altered in both
the core and the periinfarct areas at both 24 h and 3 d after
permanent middle cerebral artery occlusion (pMCAo) in rats.
Results
Early and Delayed Transcriptional Regulation Following
Cerebral Infarct
Tissue samples were obtained from different areas of the rat
brain (core, periinfarct and contralateral cortex) at 24 h (early
stage) or 3 d (delayed injury) after permanent middle cerebral
artery occlusion (pMCAO). We designed a protocol to minimize
variability and improve the reproducibility of the results. For
microarray analysis a total of 60 animals (n = 12 for each
condition; 5 groups) and 48 microarrays were used (4 micro-
arrays/condition; RNA samples from 3 independent animals were
pooled in each microarray) (Figure 1); results obtained from
ischemic and sham-operated animals were compared with results
from healthy animals. We used healthy animals as the control
group as we did not find significant differences between sham-
operated and healthy animals. In order to gain in simplicity and
Figure 1. The pMCAO model produced cortical infarcts where core, periinfarct, and contralateral areas were isolated for RNA
extraction. Sprague-Dawley rats were subjected to permanent middle cerebral artery occlusion with a 9-0 suture for 24 h or 3 d (a) Schematic
drawing of brain areas used for tissue sampling and RNA extraction. (b) Panel shows workflow and study groups used (n = 12 animals/condition). * = 4
RNA pools/condition (1 pool = 3 animals = 1 microarray). (CT: Contralateral cortex; PI: Periinfarct; C: Core).
doi:10.1371/journal.pone.0052121.g001
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since bloodflow in the contralateral cortex is also reduced in the
3VO model of pMCAO and thus the tissue cannot be considered
entirely healthywe did no further analysis of the contralateral
hemisphere.
The analyzed brain regions responded with different spatial and
temporal patterns after the ischemic insult. Hierarchical clustering
of the genes with changes in expression in at least 1 condition vs.
healthy samples (Figure 2A) showed that brain areas subjected to
experimental ischemia (core and PI) grouped together and were
differentiated from the other conditions (Contralateral cortex, or
Sham-operated). Only 165 genes showed an adjusted p-value of
less than 0.05 for the comparison between sham-operated and
healthy rats. A large number of genes were differentially expressed
in the infarct core (2,612) 24 h after permanent ischemia
compared with the same ipsilateral regions from healthy animals
(Table 1). A similar situation occurred in the PI area, where 3,505
genes changed their expression levels at 24 h (1,805 up- and 1,700
down-regulated) with logFC’s greater than 5 in many cases. In
another independent subgroup of animals analyzed after 3 d the
situation was reversed with 1,686 genes regulated in PI and a total
of 5,717 genes in the core compared with gene expression in
healthy animals.
To identify common regulatory responses, we clustered the
genes into Venn diagrams according to their type of regulation
(up/down), brain region and also time after ischemia induction
(Figure 2B). The expression of more than 300 genes (both up-
and down-regulated) changed specifically in the core of the infarct
at 24 h compared with healthy animals, and more than 700 genes
were altered in the PI area at the same time. After 3 d, more than
2,500 genes were regulated in the core of the lesion but only 13
genes were found to be specific to the PI. Thus, different patterns
were observed. A total of 120 genes that were elevated in the PI
area at 24 h remained upregulated after 3 d, whereas another
subset of 324 genes upregulated at 24 h (and common to both the
Figure 2. Focal cerebral ischemia induces early and delayed gene regulation with different patterns in core and periinfarct areas.
RNA was isolated (Qiagen RNeasy) and hybridized to Agilent chips (4644 K). (a) Upper part of the Heat map of the genes with an at least 2-fold
change in expression in at least one condition after 24 h and 3 d of permanent cerebral infarct vs. levels in healthy samples. Each experimental
condition is given at the bottom. PI = Periinfarct area; Clat = Contralateral cortex; Ips = Ipsilateral area. Vertical ‘‘Y’’ axis shows individual genes.
Red = Up; Black = no change; Green = down. (b) Venn diagrams of upregulated and downregulated genes showing differences between core (C) and
periinfarct (PI) at 24 h and 3 days of ischemia compared with healthy individuals (logFC = |1|; P,0.05).
doi:10.1371/journal.pone.0052121.g002
Table 1. Number of genes differentially regulated at 24 hours
and 3 days after pMCAO.
Total regulated
probes 24 h 3 d 24 h 3 d





Total 2,612 3,505 5,717 1,686 202 1,165
Upregulated 1,495 1,805 2,882 1,436 51 971
Downregulated 1,117 1,700 2,835 250 151 194
PI = Periinfarct, pMCAO = permanent middle cerebral artery occlusion.
P,0.05; logFC $ |1|.
doi:10.1371/journal.pone.0052121.t001
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core and PI areas) was not detected after 3 d. Indeed, a total of
539 new genes found to be common to both core and PI at 3 d
had not been elevated before. A total of 820 genes (out of 7341
regulated transcripts) were common to all times and areas. In
order to compare our data with previous findings, 300 genes
(randomly selected among all the conditions) were manually
curated in search of a relation to ‘‘cerebral ischemia’’, ‘‘cerebral
infarct’’ or ‘‘stroke’’ (http://www.ncbi.nlm.nih.gov/pubmed/).
Forty-seven percent of the regulated genes were found to be
associated with one or more of the mentioned terms whereas
almost half of the genes (43%) did not seem to have been
previously mentioned in any experimental or clinical stroke study
(Figure 3). These results indicate that our study not only validates
previous findings but also extends our knowledge of ischemia-
induced gene regulation.
Biological Functions Regulated in Core and Periinfarct
after Cerebral Infarct
To identify biological functions that were significantly altered in
brain areas subjected to infarct in comparison with healthy
animals, all the regulated genes were clustered according to several
functional categories using Ingenuity Pathway Analysis software
(www.ingenuity.com), (Figure 4).
24 h and 3 d after permanent ischemia the most altered IPA
biofunctions were cellular movement and inflammatory response.
Growth and proliferation, cell death, cell signaling and tissue
development-associated genes were highly up- and down-
regulated after cerebral infarct in core and PI areas.
Inflammatory response. The expression of multiple cyto-
kines and their receptors was dysregulated in the microarrays,
including Interleukin (IL)-1Beta, IL-18, IL-33 and also the receptors
IL-4RA, IL-6RA, IL-7R, IL13RA1 and IL17RE at both 24 h and
3 d (Table 2). Additional regulated genes included HLA-DRA and
HLA-DRB as well as genes related to cell division and expansion of
immune cells. Some of the genes were only regulated at one or the
other time-point; an example is IL-33, which was significantly
altered at 24 h after cerebral infarct in the PI area, but not at 3 d.
Cellular movement. Specific changes related to tissue
remodeling and cell migration observed in the core and the PI
areas included SEMA3A and SEMA4F (downregulated 24 h after
stroke in the PI area) (Table 2). Also, the NOS3 gene was
upregulated 24 h after cerebral infarct in both areas but not after
3 d. CXCR4 was upregulated 3 d after stroke in both the core and
PI area. ICAM1, ADM, FN1 and S100A9 were upregulated in all
samples at both times.
Gene expression. The expression of key transcription factors
for cell development and proliferation was altered (Table 3).
HIF1A mRNA levels were augmented at 24 h after stroke as were
levels of REST, a repressor of neuronal differentiation that was
upregulated in the core and PI area at 24 h and 3 d after cerebral
infarct. The same was observed with MYC and FAS. SMAD1
(related to BMP signaling) and HEY1 (related to Notch signaling)
were significantly altered only in the 24 h samples.
Tissue development. Several matrix-methaloproteinases
such as MMP2, MMP7, MMP9 and MMP12, were up-regulated
after cerebral infarct. MMP2 and MMP7 were only regulated after
3 d (Table 3). NEUROD1 was only down-regulated in the core of
the lesion. NOG gene (Noggin), was downregulated in the PI area at
3 d and HES5, involved in neurogenesis, was downregulated in
both the core and PI areas at 24 h but only in the core of the lesion
at 3 d after cerebral infarct.
Cellular growth and proliferation. Many genes related to
cell division were also regulated (Table 4). NRP1 was observed to
be elevated only in the core 3 d after stroke and NDN gene was
down-regulated in the PI area at 24 h. Except for VEGFC at 24 h
after cerebral infarct, which was lower, the other VEGF genes (A
and B) were not significantly altered at either time-point. In
general, many regulators of the cell cycle showed elevated
expression levels, including CDC2, CDK2, CCNA2, CCND1,
S100A6 and RHOH. The MAP2 gene was not regulated although
there was a tendency toward lower levels in the core at 3 d. The
mRNA levels of BAI1 were decreased at both 24 h and 3 d after
stroke in the core but only at 24 h in the PI area.
Figure 3. Microarray analysis leads to the identification of hundreds of genes not previously associated with stroke. Pie-chart
showing the percentage of genes already associated with stroke or cerebral ischemia, the percentage of genes that were not associated, and the
percentage of EST’s identified in this study. Percentages were calculated from a list of 300 genes selected by chance from the output of Venn
diagrams and considering all the experimental conditions (24 h, 3 d, core and periinfarct). (EST: Expressed sequence tag).
doi:10.1371/journal.pone.0052121.g003
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Nervous system development and function. The expres-
sion of many trophic factors as well as several neurogenesis- and
oligodendrogenesis-related genes was altered (Table 5). The
oligodendrocyte differentiation repressor LINGO1 was down-
regulated in the PI area at 24 h and remained at lower expression
values in the core of the lesion after 3 d of ischemia. On the other
hand, 24 h and 3 d after occlusion, RTN4 (Nogo-A) and its receptor
were downregulated in both the core and PI areas while OLIG2
was downregulated in the core only at 24 h. NRCAM, SYN1,
GRIN1, and ROBO2 were downregulated in the PI area but not
core at 24 h and in the core but not PI at 3 d. Most of the trophic
factors showed augmented levels after stroke. NTF4, HB-EGF and
TGFB2 were already augmented at 24 h in both core and PI areas
whereas at 3 d TGFB1, GFAP and FGF2 expression levels had also
risen in both areas. GRN (Granulin) gene expression was augmented
after 3 d. BMP4 levels were diminished at 24 h and BMP7 levels
were augmented in the core of the lesion at 3 d. Some genes like
BDNF presented a differential response, since their levels were
augmented at 24 h but had decreased at 3 d of ischemia.
DNA replication, recombination and repair. The stress
response following stroke induced several replication-associated
genes such as CDT1 and E2F3 (Table 6). At both 24 h and 3 d
after cerebral infarct the expression of repair and recombination
genes such as EXO1 was higher. Levels of ADA were also
increased at both time points.
Cell death. Expression values of genes belonging to both the
extrinsic and intrinsic pathways of apoptosis changed. CASP3 was
augmented 24 h after stroke in the core of the lesion, whereas
CASP9 and AIFM3 levels were decreased after cerebral infarct in
both core and PI areas, but these differences with normal levels
were not significant in the PI area 3 d after the lesion (Table 6).
Levels of BCL2 and ADORA1 were decreased at 24 h in the PI area
although BID mRNA levels were not significantly altered. CASP8
and BIRC5 genes were elevated after 3 d. Looking at chaperonins,
HSP27, HSPA1A, HSPA1B and HSPA2 were always increased in
both areas at both time-points, although the increase in the PI area
at 3 d did not quite reach significance.
Cellular assembly and organization. RHOA expression
did not change at either time-point, whereas the levels of FEZ1
Figure 4. Biological functions that were significantly regulated in both core and periinfarct following focal cerebral ischemia.
Biological functions calculated using Ingenuity pathway analysis (IPA) showed that all functions were significantly regulated in both core and
periinfarct (PI) following pMCAO in both the 24 hour and 3 day groups (P,0.05; B – H Multiple testing p-value correction was selected).
doi:10.1371/journal.pone.0052121.g004
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and TNR diminished in the PI area at 24 h (Table 7). SMC4,
NUF2 and ECT2 were augmented in the core and PI areas at 3 d
after stroke.
Cell signaling. Multiple genes related to cell signaling
changed during the response to ischemia, and many of them
showed increased RNA levels (e.g. CXCL1, CXCL10, CXCL11 and
CXCL13). At 24 h CXCL12 levels were decreased in transcript 3
(Table 7) but there were no changes in this transcript at 3 d and
none in transcript 1 at either of the studied time points. CCL2,
CCL4, CCL5, CCL20 and MyD88 showed augmented levels and
ANGPT2 had elevated core levels both 24 h and 3 d after ischemia
but not in PI at 3 d.
Comparison between Core and PI Gene Expression
To go a step further in our analysis of expression level, the
differences between the core and PI were statistically analyzed at
24 h and 3 d (Table 1). The number of differentially expressed
genes increased from 202 at 24 h to 1,165 at 3 days. K-mean
clustering revealed tendencies and common patterns for some of
the genes and IPA functional analysis identified relationships
between the genes whose expression levels had changed
(Figure 5).
The most upregulated genes in the core at 24 h (Fold-Changes
are given in parenthesis) were: OPRK1 (4.73); CBLN1 (4.67);
SLC6A5 (4.12); CCL21 (3.23); ATOH7 (3.16); HAS2 (3.075);
CRABP1 (2.81); HS3ST2 (2.806); INHBA (2.74); and GIPR (2.71).
The most downregulated genes were CCL11 (0.122); SLC22A1
(0.153); SLC6A20 (0.157); DLX3 (0.157); SFPQ (0.170); LNX2
(0.194); DLK1 (0.197); Cyp2b13/Cyp2b9 (0.208); CLDN19 (0.222)
and ALDH1A2 (0.222). The most significant IPA-biofunctions
[2log(B–H) p-value) is given] were cell assembly and organization
(3.55), cellular function and maintenance (3.54), cellular de-
velopment (3.05), tissue development (3.01), nervous system
development and function (2.90) and, last, cell movement (2.87).
At 3 d, the most upregulated genes in the core (Fold Changes
are given in parenthesis) were: CD8A (14.52); FABP4 (14.82);
CLEC2A (14.62); HK3 (9.81); PLAU (7.96); SPP1 (7.77); CST7
(7.37); SCIN (7.35); TREM1 (7.29) and ATP6V0D2 (7.19). The
most downregulated were: ARR3 (0.236); SLC12A1 (0.295);
CAMK2A (0.318); FRAS1 (0.335); PRKG2 (0.345); UNC45B
(0.347); TNNC2 (0.350]; SCGN [logFC (0.317); FCHO1 (0.354)
Table 2. Regulation of inflammatory response and cell movement-associated genes in the core and perriinfarct after permanent
focal cerebral ischemia.
Symbol Gene Name 24 h 3 d
Core Periinfarct Core Periinfarct
Inflammatory Reponse
TLR2 Toll-Like Receptor 2 2.59 (,1024) 2.36 (,0.01) 8.34 (,10210) 4.00 (,1024)
IL1RL1 Interleukin 1 receptor-like 1 13.8 (,1024) 15.5 (,1025) 57.7 (,1028) 12.2 (,1024)
IL1B Interleukin-1 beta 21.9 (,1027) 13.3 (,1026) 13.5 (,1026) 3.89 (,0.05)
IL4RA Interleukin-4 receptor, alpha 4.17 (,1025) 4.06 (,1025) 5.24 (,1027) 2.53 (,0.01)
IL6RA Interleukin-6 receptor, alpha 2.87 (,1026) 3,43 (,1028) 3.92 (,1029) 2,53 (,1025)
IL7R Interleukin-7 receptor 2.42 (,0.05) 2.13 (,0.05) 5.24 (,1025) 3.23 (,0.01)
IL13RA1 Interleukin 13 receptor, alpha 1 2.81 (,0.01) 2.69 (,0.01) 5.28 (,1026) 2.48 (,0.05)
IL17RE interleukin 17 receptor E – 4.63 (,1026) – –
IL18 Interleukin-18 2.11 (,0.05) 2.73 (,1025) 8.05 (,10211) 3.53 (,1026)
IL33 Interleukin-33 – 0.50 (,1025) – –
Cellular Movement
SEMA3A Semaphorin-3A – – 0.34 (,1025) –
SEMA4F Semaphorin-4F – 0.46 (,1025) – –
NOS3 Nitric oxide synthase 3 2.62 (,1024) 2.49 (,1024) – –
GUCY1A3 Guanylate cyclase soluble subunit alpha 3 0.29 (,1026) 0.42 (,1024) 0.40 (,1024) –
ADM Adrenomedullin 4.29 (,1025) 3.92 (,1025) 3.97 (,1026) 2.06 (,0.05)
HAS1 Hyaluronan synthase 1 144.01 (,1029) 145.2 (,1029) 14.52 (,1025) 4.92 (,0.05)
CXCR4 C-X-C chemokine receptor type 4 – – 9.51 (,1028) 3.25 (,0.01)
COL4A1 Collagen, type IV, alpha 1 3.73 (,1024) 4.11 (,1025) 5.43 (,1026) 2.62 (,0.01)
FN1 Fibronectin 2.36 (,1024) 3.27 (,1025) 8,18 (,1029) 3.36 (,1024)
ICAM1 Intercellular Adhesion Molecule 1 5.73 (,1027) 5.54 (,1027) 5.31 (,1027) 2.64 (,0.01)
PAK1 Serine/threonine-protein kinase PAK 1 – 0.45 (,1025) 0.44 (,1025) –
S100A9 S100A9 20.4 (,1025) 15.1 (,1024) 29.7 (,1026) 8.81 (,0.01)
SLIT2 calgranulin-B – 0.49 (,1025) – –
STAT3 Signal transducer and activator of transcription 3 3.97 (,1028) 3.29 (,1026) 2.66 (,1024) –
NRCAM Neuronal cell adhesion molecule – 0.44 (,1025) 0.41 (,1026) –
Expression is given by fold change in value compared with healthy controls. Adjusted p-value (AdjP) is given in parenthesis.
doi:10.1371/journal.pone.0052121.t002
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and WDR26 (0.37) and the most significant IPA-biofunctions
[2log(B–H) p-value) is given] were nervous system development
and function (28.3), cell-to-cell signaling and interaction (25.8),
cellular movement (22.55), cellular development (22.1), cell death
(21.5), and cellular growth and proliferation (20.9). There were
differences in the levels of expression for many genes and also for
several functional categories related to nervous system develop-
ment and function between the core and PI.
Validation of Microarray Data by qRT-PCR
In order to validate our results, a total of 22 genes (19 regulated
genes plus 3 housekeeping genes) were analyzed by Real-Time
(RT)-PCR (Figure 6). In general, the PCR findings and the
microarray data showed good agreement regarding the magnitude
of change of the logFC values.
Discussion
To the best of our knowledge this is the most detailed study of
gene expression following permanent focal cerebral infarct avail-
able to date. Thousands of transcripts were found to undergo
expression regulation (p.2) at 24 h and 3 d following pMCAO in
the ischemic core and surrounding periinfarct cortex.
The real differences between humans and animal models made
it difficult to select specific time-points for our study that could also
reflect the human situation. The initial analysis time of 24 h was
selected because it has been reported that infarct size would be
well stabilized in the pMCAO model by then and repair responses
would probably be most detectable [10]. The second analytic
time-point was 3 d since it would be difficult to distinguish
a functional penumbra (compromised periinfarct) at more than 3
to 5 days after pMCAO in the rat. Furthermore, after this time-
point what would probably be found would be late neuronal (and
non-neuronal) cell death instead of pannecrosis from the infarct
itself. The study examined a large number of individuals (60) so as
to guarantee the validity of the results. Samples were pooled and
hybridized to a feasible number of arrays. Marker candidates were
verified using RT-PCR in an independent set of rats. While the
use of pooled samples can help understand the processes undelying
the events following focal cerebral infarct [16], a more thorough
study in single individuals must be performed to validate potential
biomarkers.
Gene Expression Profiles in Cerebral Infarct (Core and PI),
Sham and Healthy Groups
A large number of genes were found to be differentially
expressed after permanent cerebral infarct; some of these
differences did not change with either the area studied or the
time elapsed since infarct and probably reflects common universal
responses to ischemic stress as well as common repair mechanisms.
Focused on this time-points, the study revealed different patterns
of gene regulation at 24 h (acute phase) and at 3 d (delayed
response).
Globally, we observed two independent time patterns in the
core and PI areas. The number of regulated genes in the PI area
decreased between 24 h and 3 d. In contrast, even though many
changes were observed in the core at 24 h, there were even more
Table 3. Regulation of gene expression and tissue development-associated genes in the core and periinfarct after permanent
focal cerebral ischemia.
Symbol Gene Name 24 h 3 d
Core Periinfarct Core Periinfarct
Gene Expression
REST RE1-silencing transcription factor 2.33 (,0.01) 2.97 (,0.01) 3,81 (,1026) 2.16 (,0.05)
SMAD1 SMAD family member 1 2.35 (,1029) 2.69 (,10211) – –
STAT4 Signal transducer and activator of transcription 4 0,49 (,0.01) – 0.35 (,1026) –
FAS TNF receptor superfamily, member 6 3.73 (,1025) 4.08 (,1025) 7.16 (,1028) 4.32 (,1025)
MYC Myc proto-oncogene protein 7.62 (,1029) 6.87 (,1028) 6.15 (,1029) 3.01 (,1024)
HIF1A Hypoxia-inducible factor 1, alpha 2.11 (,1028) – – –
ARNT2 Aryl hydrocarbon receptor nuclear translocator 2 – – – –
Tissue Development
NOTCH3 Neurogenic locus notch homolog protein 3 – 2.14 (,0.05) 2,45 (,0.05) –
NOCTH4 Neurogenic locus notch homolog protein 4 – 2.03 (,1024) – –
NOG Noggin – – 0,42 (,1026) –
SOX7 Sox-7 transcription factor 6.77 (,1027) 5.03 (,1026) 3.97 (,1026) 2.20 (,0.05)
HES1 Transcription factor HES-1 – – – –
HES2 Transcription factor HES-2 – 3.14 (,0.05) – –
HES5 Transcription factor HES-5 0.18 (,1026) 0.16 (,1026) 0.41 (,0.01) –
NEUROD1 Neurogenic differentiation 1 0.40 (,1025) – 0.36 (,1026) –
MMP2 Matrix metalloproteinase-2 – – 5.82 (,10210) 3.81 (,1026)
MMP7 Matrix metalloproteinase-7 – – 81,0 (,1027) 13,0 (,0.01)
MMP9 Matrix metalloproteinase-9 5.94 (,1026) 4.03 (,1025) 3.01 (,1024) 2.31 (,0.05)
MMP12 Matrix metalloproteinase-12 24,8 (,1025) 27,7 (,1025) 125 (,1028) 22,3 (,1024)
Expression is given by fold change in value compared with healthy controls. Adjusted p-value (AdjP) is given in parenthesis.
doi:10.1371/journal.pone.0052121.t003
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at 3 d after the occlusion. Both areas presented strong regulation
of gene expression at 24 h post-stroke, but the response was even
more notable at the late stage (3 days). Previous reports suggested
that the penumbra (in terms of volumetric analysis) might remain
differentiated from the core from the first hours to as long as 3–5
days after ischemia under conditions of a permanent MCA
occlusion [13]. Our results suggest gene expression is quite
different at distinct pivotal time-points in the pMCAO model.
Inflammatory Response and Cellular Movement
We were interested in identifying the biofunctions that were
associated with the highest number of affected genes. With the
permanent cerebral infarct, the most altered IPA-biofunctions
were those for cellular movement and inflammatory response.
Common ischemia-regulated genes, including IL-1B and IL-
13RA1, were also reported in previous microarray reports of
transitory ischemia [17]. As expected, pro- and anti-inflammatory
receptors such as IL-4RA, IL-6RA, IL-7R and IL-17RE were also
altered. Most of the observed changes probably reflect lymphocyte
recruitment to the damaged lesion site. In our study the
upregulation of TLR2 was particularly marked at 3 d of
permanent ischemia. It has been reported that activation of the
toll-like receptor (TLR) signaling pathway exacerbates ischemic
brain damage and, in fact, TLR ligand administration has been
shown to promote a certain tolerance by reprogramming TLR
function [18]. Indeed TLR2 signaling suppression could also be
a valuable approach to minimizing postischemic inflammation
that might have clinical interest. [19].
The expression levels of a large number of transcripts related to
cellular movement were also altered. In our data CXCR4 was
upregulated at 3 d after permanent occlusion in both the core and
PI area and this result was confirmed by qRT-PCR. Previous
reports on permanent ischemia in mice describe CXCR4 fluores-
cent staining in white matter as well as PI areas at 3 d and later
[20]. CXCR4 upregulation might reflect migration of immune
cells but also of neuroblasts and vasculature remodeling after
damage. Indeed, pharmacological modulation of CXCR4 signal-
ing has recently been used as a therapeutic approach [21].
Many methalloproteinases showed highly altered expression,
includingMMP2 andMMP7 at 3 d after cerebral infarct, as well as
MMP9 and MMP12 in the acute (24 h) phase. All these changes
suggest tissue matrix and cell-interaction remodeling from the first
stages of a cerebral infarct. In a recent study of MMP inhibition
after transitory ischemia, treatment with Ro 28-2653 was effective
during the first two days but not at later times or for longer periods
[22]. Consequently, MMP inhibition could be useful only at
specific stages of remodeling.
Cellular Growth & Proliferation and CNS Development
Multiple genes associated with neurovascular development were
also affected. LINGO1, a repressor of oligodendrocyte develop-
ment, was downregulated in the periinfarct area 24 h following
stroke as was RTN4 (NOGO-A) and its receptor RTN4R. LINGO1
was still significantly downregulated in the core after 3 days. These
changes might reflect a decrease in the number of precursor and
mature oligodendrocytes, as other authors have suggested may
occur 48 hours after a transient cerebral infarct [23]. The
Table 4. Regulation of cell growth and proliferation-associated genes in the core and periinfarct after permanent focal cerebral
ischemia.
Symbol Gene Name 24 h 3 d
Core Periinfarct Core Periinfarct
Cell Growth and Proliferation
CDC2 Cyclin-dependent kinase 1 5.73 (,0.01) 4.17 (,0.05) 64,5 (,1029) 20,1 (,1025)
CDK2 Cyclin-dependent kinase 2 – – 2,75 (,0.05) 2.03 (,0.01)
MAP2 Microtubule-associated protein 2 – – – –
CDK5R1 Cyclin-dependent kinase 5,regulatory subunit 1 – – 0.46 (,0.01) –
CCNA2 Cyclin A2 3.95 (0.01) 3.20 (,0.01) 33,9 (,10210) 10,3 (1026)
CCND1 Cyclin D1 2.48 (,1024) 2,00 (,0.01) 6.15 (,1029) 2.79 (1024)
NRP1 Neuropilin 1 – – 2.07 (,1027) –
BAI1 Brain-specific angiogenesis inhibitor 1 0.49 (,1024) 0.46 (,0.05) 0.37 (,0.01) –
NDN Necdin – 0.40 (,1025) – –
S100A6 S100A6 gene 3.58 (,1024) 6.28 (,1026) 11,0 (,1029) 5.39 (,1025)
INHBA Inhibin, beta A 6.77 (,1024) – – –
RUNX3 Runt-related transcription factor 3 – – – –
MAP4K1 Mitogen-activated protein kinase 1 – – 4.69 (,1027) 2.03 (,0.05)
RHOH Ras homolog gene family, member H 2.08 (,0.05) 2.11 (,0.05) 6.54 (,1027) 2.95 (,0.01)
VEGFA Vascular endothelial growth factor A – – – –
VEGFB Vascular endothelial growth factor B – – – –
VEGFC Vascular endothelial growth factor C 0.42 (,1028) – – –
FGF13 Fibroblast growth factor 13 0.47 (,1025) 0.46 (,1025) 0.33 (,1028) –
GNAO1 Guanine nucleotide binding protein – – – –
Expression is given by fold change in value compared with healthy controls. Adjusted p-value (AdjP) is given in parenthesis.
doi:10.1371/journal.pone.0052121.t004
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decreased levels of both LINGO1 and NOGO-A might initially seem
to be due to a lower number of OPCs and also OLCs, but the
transferrin gene (TF), which is only found in oligodendrocytes in the
adult brain [24], was upregulated at both 24 h and 3 d after
stroke. Although hard to interpret by only examining RNA levels,
the reduction in LINGO1 and NOGO-A might reflect an early
activation of remyelination in immature OPCs.
The expression values of important genes for neurogenesis such
as HES1, HES2, HES5, SOX2, SOX6 and SOX7 were also
altered. HES2 was upregulated in the PI area and this was
confirmed by qRT-PCR. HES5 was strongly downregulated and
SOX2 also showed a tendency to be decreased in the acute phase.
Since inactivation of both HES1 and HES5 has been reported to
promote neurogenesis [25], HES1 could be a potential therapeutic
target in ischemic conditions. A possible future strategy might be
to check the levels of some SOX6 and HES5 regulators such as
miR-219 or miR-338 and their therapeutic potential in stroke
[26]. On the other hand, the SOX7 gene, which has not previously
been associated with stroke, was highly upregulated at both 24 h
and 3 d after ischemia in the core and PI areas and recent data
suggest it has a role in vascular development [27]. This would
make it interesting to analyze the exact role of SOX7 in post-stroke
angiogenesis.
The expression of neuronal and synaptic markers such as DCX
(doublecortin) and SYN1 (Synapsin) was diminished. NUMB gene
expression was also decreased, though not significantly, and the
NEUROD1 gene was also downregulated. SYP (Synaptophysin) was
also diminished in the core after 3 d. Most of these data seem to
suggest acute inhibition of neurogenesis, but the SYPL2 gene
(Synaptophysin-like-2) and the neurogenesis marker DPYSL3 (TUC-4)
were augmented in the core at 3 d after cerebral infarct, probably
reflecting early brain repair responses after damage.
In transient models of ischemia there is a rapid upregulation of
VEGF [28]. Nevertheless, the role of VEGF remains unclear. Its
expression after ischemia increases permeability and therefore the
risk of edema [29]. In our permanent ischemia model two of the
VEGF genes (A and B) were not upregulated at 24 h or 3 d after
permanent ischemia, although VEGFC was downregulated at 24 h
but not at 3 d. This result was confirmed by PCR, and the
biological relevance of this observation, if any, is still unknown. We
detected increased levels of the transcription factor HIF1A during
the acute phase at 24 h and also of some of its downstream targets
like ADM (Adrenomedullin) or ANGPT2 (Angiopoietin), in agreement
with earlier reports [30].
Multiple trophic factors were also upregulated at 24 h including
NTF4, FGF2, TGFB1 and BDNF. All these observations might
reflect acute repair responses that are activated to induce
Table 5. Regulation of nervous system development and function-associated genes in the core and periinfarct after permanent
focal cerebral ischemia.
Symbol Gene Name 24 h 3 d
Core Periinfarct Core Periinfarct
Nervous System Dev. & Function
SYN1 Synapsin I – 0.40 (,1025) 0.42 (,1025) –
TF Transferrin 2.16 (,0.01) – 2.68 (,1025) 2.11 (,0.01)
LINGO1 Leucine rich repeat and Ig domain containing 1 – 0.44 (,1024) 0.33 (,1025) –
RTN4 (NOGO) Reticulon-4 0.44 (,0.01) 0.34 (,1024) 0.35 (,1024) 0.49 (,0.05)
RTN4R Reticulon-4 receptor 0.50 (,1024) 0,.40 (,1025) 0.39 (,1026) –
BMP4 Bone morphogenetic protein-4 0.40 (,1025) 0.43 (,1024) – –
BMP7 Bone morphogenetic protein-7 – – 2.39 (,1025) –
GRN Granulin – – 10.3 (,10211) 4.76 (,1026)
GRIN1 Glutamate [NMDA] receptor subunit zeta-1 – 0.49 (,1025) 0.41 (,1027) –
ROBO2 Roundabout, axon guidance receptor, homolog 2 – 0.49 (,1024) 0.46 (,1025) –
GFAP Glial fibrillary acidic protein 7.52 (,1026) 10.1 (,1027) 11.5 (,1028) 9.19 (,1026)
FGF2 Fibroblast growth factor 2 3.65 (,1028) 3.94 (,1028) – 2.16 (,1024)
HB-EGF Heparin-binding EGF-like growth factor 4.23 (,1025) 3.41 (,1024) – –
TGFB1 Transforming growth factor, beta 1 3.61 (,1024) 2.71 (,0.01) 8.81 (,1028) 3.61 (,1024)
TGFB2 Transforming growth factor, beta 2 3.05 (,10210) – – –
BDNF Brain-derived neurotrophic factor 2.66 (,0.05) – 0.27 (,0.01) –
NTF4 Neurotrophin 4 2.27 (,0.01) 3.81(,1026) – –
ARTN Artemin 2.81 (,0.01) – – –
YWHAH 14-3-3 protein eta – 0.47 (,1024) – –
PTN (NEGF1) Pleiotropin – – – –
NRCAM Neuronal cell adhesion molecule – 0.44 (,1025) 0.41 (,1026) –
DCX Doublecortin – – 0.50 (,1024) –
NUMB Protein numb homolog – – – –
DPYSL3 DPY-related protein 3 – – 2.14 (,1024) –
Expression is given by fold change in value compared with healthy controls. Adjusted p-value (AdjP) is given in parenthesis.
doi:10.1371/journal.pone.0052121.t005
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neurogenesis and oligodendrogenesis in the post-ischemic brain
within 24 h. It has been suggested that brain repair responses start
at the very beginning of the infarct [8]. Gene expression levels
change at different stages. BDNF upregulation was observed in the
acute phase but, surprisingly, it was downregulated at 3 d and this
result was also confirmed by PCR, meriting further investigation.
The upregulation of BDNF has been reported by other authors
[30]. In a recent paper elevated levels of BDNF have been
observed at 4 h and 24 h after stroke [31] but the putative role of
BDNF as a peripheral marker in patients has been questioned as
significant changes have not been observed in the first 4 days [32].
We wonder whether the negative result might somehow be related
with the inversion observed here.
Cell Death and Cell Signaling
The total number of cytokines and chemokines that are
activated following ischemic stress is notable. It seems that stroke
response involves an acute activation of inflammation followed by
immunosuppression. We observed a rapid upregulation of
multiple cytokines and chemokines after permanent ischemia
including CXCL1, CXCL10, CXCL11 and also CCL2, CCL4, CCL5
and CCL20. All these changes may reflect signaling that allows
lymphocytes and stem cells to home in on the infarcted site and it
would be interesting to analyze their role as possible peripheral
markers.
In contrast with what we expected due to previous reports
describing SDF1 upregulation [33], we did not observe substantial
SDF1 (CXCL12) upregulation in either the microarrays or the
PCR after permanent ischemia. Indeed, we detected decreased
SDF1 levels in the core of the lesion and also in PI areas at 24 h.
This tendency toward downregulation continued at 3 d. It is
possible that an early response after permanent injury would
decrease its levels with expression returning to normal and then
upregulated values after 4 days of ischemia as has been shown in
rats after permanent ischemia at 7 d [34]. Whatever the case, it is
clear that strategies dedicated toward pharmacologically raising
SDF1 levels have shown efficacy and are promising [21].
We also observed differences in cell death and heat shock
protein (HSP) genes after permanent ischemia. There was a global
upregulation of HSP’s including HSP2, HSPA9, HSP27, HSPA1A
(HSP72). It has previously been reported that HSP27 expression is
augmented at 24 h following both mild and severe ischemia,
mainly in astrocytes but also in neurons in different ischemic
regions [35]. In addition to their relevance as possible targets for
pharmacological therapy, we would note that they may be
interesting potential markers in peripheral blood during the acute
phase.
As could be expected due to the intrinsic stress caused by
ischemia, the expression levels of several genes participating in cell
death programs were changed. These results, however, should be
carefully interpreted as both intrinsic and extrinsic apoptosis
pathways are strongly regulated at the posttranscriptional level.
Nevertheless, we observed specific changes at the RNA level for
BCL2, CASP8, CASP9 and AIFM3. We also detected upregulation
of Fas, FasL, and TNF-related apoptosis-inducing ligands in
agreement with previous reports [36].
Table 6. Regulation of DNA replication, recombination & repair and also cell death-associated genes in the core and periinfarct
after permanent focal cerebral ischemia.
Symbol Gene Name 24 h 3 d
Core Periinfarct Core Periinfarct
DNA Replication Recomb. & Repair
ADA Adenosine deaminase – 2.64 (,0.01) 6.19 (,1027) 3.12 (,0.01)
RPA1 Replication protein A1 – 0.47 (,0.01) – –
CDT1 DNA replication factor CDT1 4.76 (,1024) 3.58 (,0.01) 11.6 (,1027) 4.00 (,0.01)
E2F3 Transcription factor E2F3 – 2.01 (,1024) – –
EXO1 Exonuclease 1 3.53 (,1024) 2.99 (,1024) 13.1 (,10210) 4.44 (,1025)
Cell Death
CASP3 Caspase 3 2.43 (,1026) – – –
CASP9 Caspase 9 2.13 (,0.05) 0.32 (,1024) 0.43 (,0.01) –
BCL2 B-cell lymphoma 2 – 0.49 (,0.01) – –
AIFM3 Apoptosis-inducing factor, mitochondrion-associated 3 0.32 (,106) 0.34 (,105) 0.30 (,107) –
BID BH3 interacting-domain death agonist – – – –
CASP8 Caspase 8 – – 4.23 (,1024) –
BIRC5 Survivin – – 13.1 (,10210) 4.17 (,1024)
ADORA1 Adenosine A1 receptor – 0.47 (,0.01) – –
HSP27 (HSP18) Heat shock protein 27 43.1 (,1029) 48.8 (,10210) 15.6 (,1027) 9.78 (,1025)
HSPA1A (HSP72) Heat shock 70 kDa protein 1 52.0 (,10212) 81.6 (,10214) 2.56 (,0.01) –
HSPA1B Heat shock 70 kDa protein 1B 73.5 (,10216) 129 (,10218) 2.66 (,1024) –
HSPA2 Heat shock-related 70 kDa protein 2 3.09 (,1028) 3.03 (,1027) – –
HSPA8 (HSC70) Heat shock 70 kDa protein 8 – – – –
HSPA9 (GPR75) Heat shock 70 kDa protein 9 – 2.25 (,1027) – –
Expression is given by fold change in value compared with healthy controls. Adjusted p-value (AdjP) is given in parenthesis.
doi:10.1371/journal.pone.0052121.t006
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Last Comments
This is a comprehensive microarray study analyzing gene
expression responses in different areas of the rat brain following
permanent focal cerebral ischemia. We particularly examined
different times at which natural repair responses are most likely to
occur and detected multiple regulations of genes related to
neuronal, oligodendrocyte and vascular development as well as
cellular movement and tissue reorganization. The information
provided here is of potential utility for both the identification of
new markers and therapeutic targets as well as for the de-




All experiments were designed to minimize suffering in
compliance with our medical school’s Ethical Committee for the
Care and Use of Animals in Research (following EU directives 86/
609/CEE and 2003/65/CE).
Animals and Surgery
A total of 72 Sprague-Dawley rats weighting 250–320 gr.
(Harlan Iberica S.L.) were used; 60 for microarray analysis and 12
additional animals for qRT-PCR validation. There were 5 groups:
healthy unoperated rats (n = 12); ischemic rats at 24 h and 3 d
survival (n = 12 respectively) and sham-operated animals at 24 h
and 3 d survival (n = 12 respectively). To induce cerebral infarct,
the middle cerebral artery was occluded with a permanent 9-
0 suture in a 3VO model as previously described [37]. Briefly,
animals were anesthetized before surgery with a solution of
ketamine (25 mg/kg), diazepam (2 mg/kg), and atropine (0.1 mg/
kg) at a volume of 2.5 ml/kg by intraperitoneal injection.
Analgesia was provided with meloxicam 2 mg/kg by subcutaneous
administration and a small craniotomy was made above the rhinal
fissure over the branch of the right middle cerebral artery (MCA),
which was permanently ligated just before its bifurcation between
the frontal and parietal branches. Both common carotid arteries
were then transiently occluded for 60 min. Complete interruption
of blood flow was confirmed using an operating microscope and
indirectly confirmed by the presence of an ischemic lesion in
magnetic resonance imaging (MRI) and ADC maps of the brains.
A thermistor probe was placed under the temporal muscle and
over the cerebral artery region to measure brain temperature
while glucose, blood gases and blood pressure were monitored
(Monitor Omicron ALTEA RGB medical devices). Cranial and
body temperature were maintained at 36.560.5uC during surgery
and other physiological parameters (glycemia, blood gases and
blood pressure) were maintained within 20% deviation from
normal values An identical protocol was applied to Sham-operated
Table 7. Regulation of cellular assembly & organization and cell signaling-associated genes in the core and periinfarct after
permanent focal cerebral ischemia.
Symbol Gene Name 24 h 3 d
Core Periinfarct Core Periinfarct
Cellular Assembly & Organization
RHOA Ras homolog gene family, member A – – – –
SMC4 Structural maintenance of chromosomes 4 – – 3.83 (,1029) 2.02 (,1024)
NUF2 Kinetochore protein Nuf2 – – 19.7 (,1029) 7.36 (,1025)
ECT2 ECT2 gene 3.16 (,0.05) – 32.0 (,10210) 10.6 (,1025)
FEZ1 Fasciculation and elongation protein zeta-1 – – 0.45 (,0.01) –
TNR Tenascin-R – – 0.47 (,1027) –
Cell Signaling
RFTN1 Raftlin, lipid raft linker 1 2.12 (,0.01) 2.45 (,1024) 7.06 (,1029) 2.29 (,0.01)
NDN Necdin – 0.40 (,1025) – –
CCL5 Chemokine (C-C motif) ligand 5 – 2.39 (,0.05) 2.36 (,0.01) –
CXCL1 Chemokine (C-X-C motif) ligand 1 27.1 (,0.01) 238 (,1026) 82.7 (,1025) 27.7 (,0.01)
CXCL10 Chemokine (C-X-C motif) ligand 10 7.36 (,1024) 9.38 (,1024) 6.27 (,1024) 9.32 (,1024)
CXCL11 Chemokine (C-X-C motif) ligand 11 11.5 (,1024) 22.8 (,1025) 25.3 (,1026) 12.8 (,1024)
CXCL12 (T1) Chemokine (C-X-C motif) ligand 12 (transcript 1) – – – –
CXCL12 (T3) Chemokine (C-X-C motif) ligand 12 (transcript 3) 0.28 (,1029) 0.36 (,1027) – –
CXCL13 Chemokine (C-X-C motif) ligand 13 4.75 (,0.05) 3.48 (,0.05) 10.9 (,1025) 5.89 (,0.05)
CCL2 Chemokine (C-C motif) ligand 2 576 (,1028) 560 (,1028) 388 (,1028) 69.1 (,1025)
CCL4 Chemokine (C-C motif) ligand 4 15.8 (,1027) 14.0 (,1027) 7.94 (,1026) 2.88 (,0.05)
CCL5 Chemokine (C-C motif) ligand 5 – 2.39 (,0.05) 2.36 (,0.01) –
CCL20 Chemokine (C-C motif) ligand 20 46.2 (,1025) 90,5 (,1026) 4.86 (,0.05) –
MyD88 Myeloid differentiation primary response gene 88 2.27 (,0.01) 2.00 (,0.05) 2.71 (,1024) –
ANGPT2 Angiopoietin-2 3.41 (,0.05) 2.92 (,0.05) 2.36 (,0.05) –
CALCB Calcitonin-related polypeptide beta 18.4 (,1028) 12.2 (,1026) 61.8(,10211) 11.8 (,1026)
Expression is given by fold change in value compared with healthy controls. Adjusted p-value (AdjP) is given in parenthesis.
doi:10.1371/journal.pone.0052121.t007
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rats, which were subjected to exactly the same surgery protocol but
without occlusion. All rats were fed ad libitum in their home cages
until sacrifice at 24 h or 3 days.
Microarrays Assay, Data Pre-processing and Data Analysis
The 3VO model has been used before to study the metabolic
evolution of core and periinfarct areas [15]. Following the same
protocol we obtained highly reproducible cortical infarcts from
which core and peri-infarct areas were dissected out from the
brains for RNA isolation (Figure 1) using a commercial kit
following the manufacturer’s instructions (Qiagen RNeasy kit,
Hilden, Germany). Integrity and quantity were checked with the
Agilent Bio-Analyzer QC. Ipsilateral and contralateral samples
from healthy and sham-operated animals were also examined.
One-Color Microarray-Based Gene Expression Analysis Pro-
tocol (Agilent Technologies, Palo Alto, CA, USA) was used to
amplify and label RNA. Samples were hybridized on Whole Rat
Genome Microarrays 4644 K (G4131F, Agilent Technologies).
1.65 micrograms of Cy3-labeled aRNA were hybridized for 17
hours at 65uC in an Agilent hybridization oven (G2545A, Agilent
Technologies) set at 10 rpm in a final concentration of 16GEx
Hybridization Buffer HI-RPM (Agilent Technologies). Arrays
were washed and dried using a centrifuge according to the
manufacturer’s instructions (One-Color Microarray-Based Gene
Expression Analysis, Agilent Technologies). Arrays were scanned
at 5 mm resolution on an Agilent DNA Microarray Scanner
(G2565BA, Agilent Technologies) using the default settings for
4644 k format one-color arrays. Images provided by the scanner
were analyzed using Feature Extraction software v10.7.3.1
(Agilent Technologies). Raw signals were thresholded to 1 and
quantile normalization [38] was performed using GeneSpring
software. Data were considered in the log2 scale. Of the 41,105
probes present in the chip, 20,395 were suitable for further
analysis because they fulfilled the following criteria: (i) they
exhibited a signal within the higher 80th percentile in at least 75%
of the replicates in one condition; (ii) at least 75% of the replicates
in a given condition were flagged as present or marginal and (iii)
the coefficient of variation across samples was larger than 2.5%.
Quality control checks were based on the bioconductor package
ArrayQualityMetrics (www.bioconductor.org). All samples em-
ployed for analysis were processed using the Limma bioconductor
package [39]. For each contrast, genes with a Benjamini-
Hochberg corrected p-value below 0.05 were considered to be
differentially expressed [40]. Unless stated otherwise, each contrast
focused on those genes that were differentially expressed and with
a change of at least 2-fold between the compared conditions. The
probe ID, gene names and log fold changes (logFC) of genes
significantly expressed are listed in supplementary material (Tables
S1, S2, S3, S4, S5, and S6). Functional analyses of the
differentially expressed genes in the different contrasted conditions
were obtained using the Ingenuity Pathway Analysis tool (www.
ingenuity.com). Hierarchical and k-means clustering were per-
formed on the normalized data using Genesis [41].
Figure 5. Differential gene regulation of core and periinfarct areas following pMCAO. a) k-Means clustering showing 8 different gene
expression patterns. From left to right: Core at 24 h, Periinfarct at 24 h, Core at 3 d and Periinfarct area at 3 d; b) most significantly altered IPA
biofunctions when comparing both areas at 24 h or 3 d of ischemia.
doi:10.1371/journal.pone.0052121.g005
Figure 6. Validation of data from microarray analysis. The levels of 19 representative genes were assessed by qRT-PCR in a new set of 12
animals. Values were normalized to GAPDH, PGK1 and HMBS control genes. Data represent the means 6 SD of three independent experiments
performed in triplicate. Differences with healthy animals were arbitrarily set to 1. All changes in gene expression were significant (P,0.01). Red line
indicates FC = 1.
doi:10.1371/journal.pone.0052121.g006
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Quantitative Real-time PCR
In order to validate microarray results, an independent analysis
by qRT-PCR was performed for a subset of 22 genes (19 regulated
genes plus 3 houskeeping genes). This selection was based on their
FC values. To achieve this, a new cohort of 12 animals was used.
Total RNA was quantified (ND-1000 Nanodrop) and evaluated
for quality (2100 Bioanalyzer) before reverse transcription (High
Capacity RNA to cDNA Master Kit) using 1 mg of total RNA in
a 25 ml volume reaction. Real time PCR was performed using
Taqman (Applied Biosystems) gene expression assays (GAPD,
Rn01775763_g1; PGK1, Rn00821429_g1; HMBS,
Rn00565886_m; BDNF, Rn02531967_s1; VEGFc,
Rn01488076_m; OLIG2, Rn01767116_m; CASP8,
Rn00574069_m; PCNA, Rn00574296_g1; LINGO3,
Rn01408564_m; HSPA12a, Rn01410714_m; HES2,
Rn00570311_g1; SEMA4f, Rn00570562_m; NEFM,
Rn00566763_m; CXCL12, Rn00573260_m; CXCR4,
Rn01483207_m; BMP4, Rn00432087_m; EGR1,
Rn00561138_m; IGF1, Rn00710306_m; CALB1,
Rn00583140_m; NRN1L, Rn01762396_g1; FGF18,
Rn00433286_m; CXCL1, Rn00578225_m). Reactions were
performed using reference genes GAPDH, PGK1 and HMBS in
384-well plates using 2.5 mL of total cDNA following the
manufacturer’s instructions in a 7900 HT Fast Real-Time PCR
System (Applied Biosystems) with SDS software and RQManager.
All assays were done in triplicate.
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